EGFR and breast cancer: To analyze downstream signalling pathways of the ErbB family by immunohistochemistry (IHC), the expression of the phospho-MAPK (P-MAPK) and phospho-AKT (P-AKT) were analyzed in 178 BC randomly selected from the entire series of 286 patients included in our study.